|FOR IMMEDIATE RELEASE
Thursday, Nov. 13, 1997
Bill Hall |
NIH Office of Medical Applications of Research
November 17-19: 301-641-3813
National Institute on Drug Abuse
NIH Consensus Development Conference
on Effective Medical Treatment of Heroin Addiction
- What is the scientific evidence to support a conceptualization of opiate addiction as a medical disorder including natural history, genetics and risk factors, pathophysiology, and how is diagnosis established?
- What are the consequences of untreated opiate addiction to individuals, families and society?
- What is the efficacy of current treatment modalities in the management of opiate addiction including detoxification alone, non-pharmacological/psychosocial treatment, treatment with opiate antagonists, and treatment with opiate agonists (short-term and long-term)?
- What is the (scientific evidence for the) most effective use of opiate agonists in the treatment of opiate addiction?
- What are the important barriers to effective use of opiate agonists in the treatment of opiate addiction in the U.S. including perceptions and the adverse consequences of opiate agonist use, legal, regulatory, financial and programmatic barriers?
- What are the future research areas and recommendations for improving opiate agonist treatment and improving access?
The panel will present its draft statement to the public for comment at 9 a.m. on Wednesday, November 19. Following this public comment session, the panel will release its revised consensus
statement at a news conference at 1 p.m. and take questions from the media. Dr. Judd will moderate the news conference. The consensus statement is the report of an independent panel and is not a policy statement of the NIH or the Federal Government.
The NIH Consensus Development Program was established in 1977 as a form of "science court" to resolve in an unbiased manner controversial topics in medicine. To date, NIH has conducted 107 such conferences addressing a wide range of controversial medical issues important to health care providers, patients, and the general public. An average of six consensus conferences are held each year.
Additional information about this conference, including the meeting agenda, local area hotels, and directions to NIH, is available at the NIH Consensus Development Program Web site at http://consensus.nih.gov. To register for the conference, call 301-468-MEET, send e-mail to NIHconsensus@ProspectAssoc.com, or visit the Web site.
NOTE TO RADIO EDITORS: An audio report of the conference results will be available November 19-28, 1997 from the NIH Radio News Service by calling 1-800-MED-DIAL (1-800-633-3425) or by visiting http://www.radiospace.com/nihhome.htm on the Web.